Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer.

Zhong, Yue; Zhuang, Zhenjie; Mo, PeiJu; Shang, Qi; Lin, Mandi; Gong, JiaQian; Huang, JiaRong; Mo, HaiYan; Huang, Mei.

Afiliação

Zhong Y; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Zhuang Z; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Mo P; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Shang Q; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Lin M; Department of Breast Diseases, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Gong J; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Huang J; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Mo H; Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Huang M; Department of Breast Diseases, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Evid Based Complement Alternat Med ; 2021: 5557873, 2021.

Article em En | MEDLINE | ID: mdl-34567213

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article